Transgender Children Development Consistent with Current Gender, Not Sex Assigned at Birth
Transgender children show strong identification and preferences stereotypically associated with their current gender identities, not their sex assigned at birth.
Forest Labs’ Antidepressant Marketing Woes Continue
Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even...
Traditional South African Healers Use Connection in Suicide Prevention
Study finds that traditional healers in South Africa, whose services are widely used by the countryās population, perform important suicide prevention work.
Antidepressant Use Climbs as Patients Find it Difficult to Discontinue
Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.
Knowing Patient’s Story Improves Odds of Happy Ending
The American Academy of Family Physicians (AAFP) has released a toolkit that will help physicians identify and respond to key social determinants impacting their...
Transition into Poverty May Worsen Child and Maternal Mental Health
Transitioning into poverty linked to behavioral issues in children, but may be mitigated by motherās mental health.
The Drug Being Pushed on Nursing Home Residents
FromĀ Next Avenue: The drug Nuedexta has only been approved for patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). However, the maker of...
Call for Client Inclusion in Recovery-Focused Psychiatric Diagnosis
A new review, published in The Lancet Psychiatry, examines the perspectives of clinicians and service-users on psychiatric diagnosis.
āMartyrs to Science? When Research Participants Dieā
Neuroskeptic covers a short article by Susan Lederer that appeared in the American Medical Association Journal of Ethics discussing what happens when research participants die.
Are Different Depression Scales Measuring the Same Thing?
A new study examines the wide range of symptoms that appear on depression rating scales and what the means for the reliability of research.
Osteoporosis Associated with Antipsychotic Treatment
Chinese researchers find, in a literature review for the International Journal of Endocrinology find an increased rate of osteoporosis among people with a schizophrenia...
Psychiatrists’ Accounts of “Insight”
Researchers in the U.K. examine how "insight" into schizophrenia is represented in psychiatrists' accounts, finding "three dimensions of insight into schizophrenia in the data...
Polypharmacy/Bipolar illness
A. Bipolar Illness Before the Psychopharmacology Era
Prior to 1955, bipolar illness was a rare disorder. There were only 12,750 people Ā hospitalized with that disorder...
The Long History of Discrimination in Pain Medicine
FromĀ The Atlantic: Throughout history, doctors have often stigmatized and discounted patients suffering from pain without visible injury. The rise of X-rays and other "objective"...
How Learning New Words Could Make You Happier
FromĀ TIME: Learning new words to describe different types of happiness, well-being, and joy can increase our ability to connect with and feel those emotions....
Understanding the Psychology of Bad Science
-Nautilus explores the ideas of a psychologist who has been examining the minds behind the expanding proliferation of flawed science.
Findings Linking Depression to Abnormal Brain Activity Questioned
Meta-analyses fail to replicate findings linking abnormal brain activity to depression.
Does Active Placebo Response Explain Antidepressant Results?
A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.
DBT and Psychiatry for Borderline; Equally Poor at 2 years, But Long-Term Remission is...
A prospective study in the American Journal of Psychiatry compares Dialectical Behavior Therapy (DBT) with psychiatric management for borderline personality disorder, founding that outcomes...
Trump’s Pick to Oversee Big Pharma has Ties to Opioid Industry
FromĀ The Intercept: Newly released documents show that Dr. Scott Gottlieb, President Trump's nominee to lead the FDA, has received almost $45,000 in speaking fees...
